Achievements

Achievements

競争的資金
【研究代表者】小坂健
【研究資金】厚労科研：循環器疾患・糖尿病等生活習慣病対策総合研究事業 [2023-2024]
大規模コホートとリアルワールドデータを用いた口腔と全身疾患の関連についての研究
【研究代表者】福田治久
【研究資金】AMED：循環器疾患・糖尿病等生活習慣病対策実用化研究開発事業 [2022-2024]
高血圧発症予防に向けた先制保健介入モデルの開発
【研究代表者】福田治久
【研究資金】JST：創発的研究支援事業 [2021-2027]
健康データ創発的多地域コホート研究基盤の構築
【研究代表者】福田治久
【研究資金】AMED：ワクチン開発推進事業 [2021-2023]
保健・医療・介護・行政データを統合した大規模データベースを活用したワクチンの有効性・安全性の検証に資する研究開発
【研究代表者】福田治久
【研究資金】文部科研：基盤研究（A） [2020-2023]
レセプトデータを基軸としたデータ駆動型臨床疫学研究の基盤開発
【研究代表者】福田治久
【研究資金】AMED：長寿科学研究開発事業 [2020-2022]
ICTプラットホーム構築による介護予防サービスの実証フィールドの開発研究
【研究代表者】福田治久
【研究資金】文部科研：挑戦的研究（萌芽） [2019-2022]
地域住民の健康評価プラットフォームの開発と予防的保健医療介護事業の効果検証
【研究代表者】福田治久
【研究資金】厚労科研：長寿科学政策研究事業 [2019-2020]
エビデンスを踏まえた効果的な介護予防の実施に資する介護予防マニュアルの改訂のための研究
【研究代表者】竹内研時
【研究資金】文部科研：基盤研究（B） [2022-2026]
ビッグデータ活用による健康寿命延伸と医療・介護費抑制に資する口腔のエビデンス創出
【研究代表者】藤本雅大
【研究資金】文部科研：基盤研究（B） [2022-2025]
起立・歩行動作解析を基軸とした要介護リスク診断プラットフォームの創出
More
原著論文
Noma H*, Kurita N, Fukuma S, Fujisawa T, Oda F, Maeda M, Fukuda H.
Heart failure and renal outcomes with angiotensin receptor blockers compared with calcium channel blockers in patients with chronic kidney disease: A target trial emulation.
Heart 2026; in press.
Kusama T, Tamada Y, Miyano T, Maeda M, Oda F, Osaka K, Fukuda H, Takeuchi K*.
Non-linear Association between Tooth Loss and Cardiovascular Diseases among Middle-aged Adults.
Journal of Periodontology 2026; in press.
Kinugawa A, Tamada Y, Kusama T, Hoshi-Harada M, Ono S, Oda F, Maeda M, Yoda N, Osaka K, Fukuda H, Takeuchi K*.
Validity of denture usage definitions based on claims data in Japanese older adults.
JDR Clinical & Translational Research 2026; in press.
Noma H*, Sunada H, Sugimoto T, Sada K, Oda F, Maeda M, Fukuda H.
Angiotensin Receptor Blockers vs Calcium Channel Blockers for First-Line Antihypertensive Therapy and Survival in Adults Aged 75 Years or Older.
Journal of the American Geriatrics Society 2026; in press.
Ogata H*, Tsubouchi K, Takano T, Maeda M, Oda F, Okamoto I, Fukuda H.
Real-world evaluation of adherence to single-inhaler triple therapy in chronic obstructive pulmonary disease: the LIFE Study.
Respiratory Research 2026; in press.
Kawabata J, Goto K*, Maeda M, Fukuda H.
Comparison of post-discharge mortality and medical expenditures in COVID-19 patients according to mechanical ventilation and extracorporeal membrane oxygenation use: The LIFE Study.
Plos One 2026; 21(3): e0345939.
Murata S*, Ebeling M, Ono R, Maeda M, Schmidt‑Mende K, Fukuda H*, Modig K. Understanding Japan’s Mortality Advantage:
Understanding Japan’s mortality advantage: a comparison of mortality in independent and dependent older adults in Japan and Sweden.
BMC Medicine 2026; 24(1): 160.
Kinugawa A, Takeuchi K, Tamada Y, Kusama T, Oda F, Maeda M, Ohyama H, Osaka K, Fukuda H.
Impact of Leaving Periodontal Disease Untreated on Healthcare Expenditures: A Retrospective Cohort Study.
Journal of Periodontology 2026; in press.
Okui T*, Fukushima H, Maeda M, Oda F, Nakashima N, Fukuda H.
A short-term association between hospitalizations for mental disorders and ambient temperature in Japan: an ecological study using the LIFE Study data.
Environmental Health and Preventive Medicine 2026; 31: 12.
Shida H, Hirayama A, Kitamura T, Maeda M, Oda F, Fukuda H, Kawasaki R*.
Association between the care need level before admission and long-term outcomes in elderly patients with stroke: The Longevity Improvement & Fair Evidence (LIFE) study.
Journal of the American Medical Directors Association 2026; 27: 106165.
More
学会発表
中塚清将, 小野玲, 前田恵, 小田太史, 福田治久.
特定健診受診者における運動推奨ダイレクトメッセージと健康行動の関連：LIFE Studyによるランダム化比較試験の2次利用.
第27回日本健康支援学会年次学術大会. 2026年3月6-7日. 松江.
明野由里奈, 後藤健一, 前田恵, 小田太史, 福田治久.
特定保健指導の保健師別パフォーマンス評価の試み：LIFE Study.
第27回日本健康支援学会年次学術大会. 2026年3月6-7日. 松江.
緒方大聡, 前田恵, 小田太史, 岡本勇, 福田治久.
慢性閉塞性肺疾患に対する単一吸入器トリプル製剤間の服薬アドヒアランスの比較：LIFE Study.
第66回日本呼吸器学会学術講演会.2026年4月17日-19日. 神戸.
Ogata H, Maeda M, Oda F, Okamoto I, Fukuda H.
Real-World Evaluation of Medication Adherence to Single-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease: The LIFE Study.
American Thoracic Society Conference 2026. 2026年5月17-20日. Orland.
Maeda H, Toizumi M, Igarashi A, Maeda M, Oda F, Fukuda H.
Incidence of COVID-19 Hospitalization and Seizures by Vaccination in Youth in Japan: VENUS Study.
The 36th Annual Scientific Meeting of the Japan Epidemiological Association & The 3rd Joint Scientific Meeting with the IEA Western Pacific Region, Nagasaki, January 28-30, 2026.
Zha L, Kimura Y, Komatsu M, Shimomura Y, Gon Y, Maeda M, Oda F, Komukai S, Kiyohara K, Kitamura T, Fukuda H.
Association of PPSV23 with Parkinson’s and Alzheimer’s Disease Risk: The VENUS Study.
The 36th Annual Scientific Meeting of the Japan Epidemiological Association & The 3rd Joint Scientific Meeting with the IEA Western Pacific Region, Nagasaki, January 28-30, 2026.
Sung Y, Goto K, Maeda M, Oda F, Fukuda H.
Bias in vaccination coverage from incomplete in-migrant records in Japan: the VENUS Study.
The 36th Annual Scientific Meeting of the Japan Epidemiological Association & The 3rd Joint Scientific Meeting with the IEA Western Pacific Region, Nagasaki, January 28-30, 2026.
Chikamochi S, Mimura W, Ishiguro C, Oda F, Maeda M, Fukuda H.
Effect of missing Enrollment Registry on Vaccine Effectiveness based on NDB’s feature: VENUS Study.
The 36th Annual Scientific Meeting of the Japan Epidemiological Association & The 3rd Joint Scientific Meeting with the IEA Western Pacific Region, NagasakiJanuary 28-30, 2026.
Kono Y, Ishiguro C, Hagiwara Y, Fukuda H, Takeuchi Y.
Selection bias in the test-negative case-control design.
The 36th Annual Scientific Meeting of the Japan Epidemiological Association & The 3rd Joint Scientific Meeting with the IEA Western Pacific Region, Nagasaki, January 28-30, 2026.
Kawaguchi K, Maeda M, Oda F, Nakashima Y, Fukuda H.
Initial real-world experience with lecanemab prescribing pattern in Japan: The LIFE Study.
The 36th Annual Scientific Meeting of the Japan Epidemiological Association & The 3rd Joint Scientific Meeting with the IEA Western Pacific Region, Nagasaki January 28-30, 2026.
More